 | • レポートコード：B-GIR08C0404 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アテゾリズマブの世界市場について調べ、まとめました。種類別セグメントは、用途：単剤、用途：化学療法併用等、用途別セグメントは、等に区分しました。アテゾリズマブの世界市場概観、企業動向、企業別アテゾリズマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アテゾリズマブの市場概観 ・アテゾリズマブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アテゾリズマブの企業別販売動向、市場シェア、市場集中度、競争動向 ・アテゾリズマブの世界市場規模 ・アテゾリズマブの北米市場分析（アメリカ、カナダ、メキシコ等） ・アテゾリズマブのアメリカ市場規模推移 ・アテゾリズマブのカナダ市場規模推移 ・アテゾリズマブのメキシコ市場規模推移 ・アテゾリズマブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・アテゾリズマブのドイツ市場規模推移 ・アテゾリズマブのイギリス市場規模推移 ・アテゾリズマブのロシア市場規模推移 ・アテゾリズマブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・アテゾリズマブの日本市場規模推移 ・アテゾリズマブの中国市場規模推移 ・アテゾリズマブの韓国市場規模推移 ・アテゾリズマブのインド市場規模推移 ・アテゾリズマブの東南アジア市場規模推移 ・アテゾリズマブの南米市場分析（ブラジル、アルゼンチン等） ・アテゾリズマブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・アテゾリズマブの種類別分析/販売量、売上、市場シェア（用途：単剤、用途：化学療法併用） ・アテゾリズマブの用途別分析/市場規模（） ・アテゾリズマブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・アテゾリズマブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Atezolizumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Atezolizumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Genentech (Roche)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Use: Single Drug
Use: Chemotherapy Combination
Market Segment by Applications, can be divided into
Bladder Cancer
Lung Cancer
Advanced Triple-negative Breast Cancer
Head and Neck Cancer
Urothelial Carcinoma
Renal Cell Carcinoma
Hepatocellular Carcinoma (HCC)
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Atezolizumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Atezolizumab, with price, sales, revenue and global market share of Atezolizumab in 2017 and 2018.
Chapter 3, the Atezolizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Atezolizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Atezolizumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Atezolizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Atezolizumab Introduction
1.2 Market Analysis by Type
1.2.1 Use: Single Drug
1.2.2 Use: Chemotherapy Combination
1.3 Market Analysis by Applications
1.3.1 Bladder Cancer
1.3.2 Lung Cancer
1.3.3 Advanced Triple-negative Breast Cancer
1.3.4 Head and Neck Cancer
1.3.5 Urothelial Carcinoma
1.3.6 Renal Cell Carcinoma
1.3.7 Hepatocellular Carcinoma (HCC)
1.3.8 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genentech (Roche)
2.1.1 Business Overview
2.1.2 Atezolizumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genentech (Roche) Atezolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Atezolizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Atezolizumab Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Atezolizumab Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Atezolizumab Manufacturer Market Share in 2018
3.3.2 Top 6 Atezolizumab Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Atezolizumab Market Analysis by Regions
4.1 Global Atezolizumab Sales, Revenue and Market Share by Regions
4.1.1 Global Atezolizumab Sales and Market Share by Regions (2014-2019)
4.1.2 Global Atezolizumab Revenue and Market Share by Regions (2014-2019)
4.2 North America Atezolizumab Sales and Growth Rate (2014-2019)
4.3 Europe Atezolizumab Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Atezolizumab Sales and Growth Rate (2014-2019)
4.5 South America Atezolizumab Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Atezolizumab Sales and Growth Rate (2014-2019)
5 North America Atezolizumab by Country
5.1 North America Atezolizumab Sales, Revenue and Market Share by Country
5.1.1 North America Atezolizumab Sales and Market Share by Country (2014-2019)
5.1.2 North America Atezolizumab Revenue and Market Share by Country (2014-2019)
5.2 United States Atezolizumab Sales and Growth Rate (2014-2019)
5.3 Canada Atezolizumab Sales and Growth Rate (2014-2019)
5.4 Mexico Atezolizumab Sales and Growth Rate (2014-2019)
6 Europe Atezolizumab by Country
6.1 Europe Atezolizumab Sales, Revenue and Market Share by Country
6.1.1 Europe Atezolizumab Sales and Market Share by Country (2014-2019)
6.1.2 Europe Atezolizumab Revenue and Market Share by Country (2014-2019)
6.2 Germany Atezolizumab Sales and Growth Rate (2014-2019)
6.3 UK Atezolizumab Sales and Growth Rate (2014-2019)
6.4 France Atezolizumab Sales and Growth Rate (2014-2019)
6.5 Russia Atezolizumab Sales and Growth Rate (2014-2019)
6.6 Italy Atezolizumab Sales and Growth Rate (2014-2019)
7 Asia-Pacific Atezolizumab by Country
7.1 Asia-Pacific Atezolizumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Atezolizumab Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Atezolizumab Revenue and Market Share by Country (2014-2019)
7.2 China Atezolizumab Sales and Growth Rate (2014-2019)
7.3 Japan Atezolizumab Sales and Growth Rate (2014-2019)
7.4 Korea Atezolizumab Sales and Growth Rate (2014-2019)
7.5 India Atezolizumab Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Atezolizumab Sales and Growth Rate (2014-2019)
8 South America Atezolizumab by Country
8.1 South America Atezolizumab Sales, Revenue and Market Share by Country
8.1.1 South America Atezolizumab Sales and Market Share by Country (2014-2019)
8.1.2 South America Atezolizumab Revenue and Market Share by Country (2014-2019)
8.2 Brazil Atezolizumab Sales and Growth Rate (2014-2019)
8.3 Argentina Atezolizumab Sales and Growth Rate (2014-2019)
8.4 Colombia Atezolizumab Sales and Growth Rate (2014-2019)
9 Middle East and Africa Atezolizumab by Countries
9.1 Middle East and Africa Atezolizumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Atezolizumab Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Atezolizumab Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Atezolizumab Sales and Growth Rate (2014-2019)
9.3 Turkey Atezolizumab Sales and Growth Rate (2014-2019)
9.4 Egypt Atezolizumab Sales and Growth Rate (2014-2019)
9.5 Nigeria Atezolizumab Sales and Growth Rate (2014-2019)
9.6 South Africa Atezolizumab Sales and Growth Rate (2014-2019)
10 Global Atezolizumab Market Segment by Type
10.1 Global Atezolizumab Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Atezolizumab Sales and Market Share by Type (2014-2019)
10.1.2 Global Atezolizumab Revenue and Market Share by Type (2014-2019)
10.2 Use: Single Drug Sales Growth and Price
10.2.1 Global Use: Single Drug Sales Growth (2014-2019)
10.2.2 Global Use: Single Drug Price (2014-2019)
10.3 Use: Chemotherapy Combination Sales Growth and Price
10.3.1 Global Use: Chemotherapy Combination Sales Growth (2014-2019)
10.3.2 Global Use: Chemotherapy Combination Price (2014-2019)
11 Global Atezolizumab Market Segment by Application
11.1 Global Atezolizumab Sales Market Share by Application (2014-2019)
11.2 Bladder Cancer Sales Growth (2014-2019)
11.3 Lung Cancer Sales Growth (2014-2019)
11.4 Advanced Triple-negative Breast Cancer Sales Growth (2014-2019)
11.5 Head and Neck Cancer Sales Growth (2014-2019)
11.6 Urothelial Carcinoma Sales Growth (2014-2019)
11.7 Renal Cell Carcinoma Sales Growth (2014-2019)
11.8 Hepatocellular Carcinoma (HCC) Sales Growth (2014-2019)
11.9 Other Sales Growth (2014-2019)
12 Atezolizumab Market Forecast (2019-2024)
12.1 Global Atezolizumab Sales, Revenue and Growth Rate (2019-2024)
12.2 Atezolizumab Market Forecast by Regions (2019-2024)
12.2.1 North America Atezolizumab Market Forecast (2019-2024)
12.2.2 Europe Atezolizumab Market Forecast (2019-2024)
12.2.3 Asia-Pacific Atezolizumab Market Forecast (2019-2024)
12.2.4 South America Atezolizumab Market Forecast (2019-2024)
12.2.5 Middle East and Africa Atezolizumab Market Forecast (2019-2024)
12.3 Atezolizumab Market Forecast by Type (2019-2024)
12.3.1 Global Atezolizumab Sales Forecast by Type (2019-2024)
12.3.2 Global Atezolizumab Market Share Forecast by Type (2019-2024)
12.4 Atezolizumab Market Forecast by Application (2019-2024)
12.4.1 Global Atezolizumab Sales Forecast by Application (2019-2024)
12.4.2 Global Atezolizumab Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Atezolizumab Picture
Table Product Specifications of Atezolizumab
Figure Global Sales Market Share of Atezolizumab by Types in 2018
Table Atezolizumab Types for Major Manufacturers
Figure Use: Single Drug Picture
Figure Use: Chemotherapy Combination Picture
Figure Atezolizumab Sales Market Share by Applications in 2018
Figure Bladder Cancer Picture
Figure Lung Cancer Picture
Figure Advanced Triple-negative Breast Cancer Picture
Figure Head and Neck Cancer Picture
Figure Urothelial Carcinoma Picture
Figure Renal Cell Carcinoma Picture
Figure Hepatocellular Carcinoma (HCC) Picture
Figure Other Picture
Figure United States Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure France Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure UK Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure China Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure India Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Atezolizumab Revenue (Value) and Growth Rate (2014-2024)
Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche) Atezolizumab Type and Applications
Table Genentech (Roche) Atezolizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Atezolizumab Sales by Manufacturer (2017-2018)
Figure Global Atezolizumab Sales Market Share by Manufacturer in 2017
Figure Global Atezolizumab Sales Market Share by Manufacturer in 2018
Table Global Atezolizumab Revenue by Manufacturer (2017-2018)
Figure Global Atezolizumab Revenue Market Share by Manufacturer in 2017
Figure Global Atezolizumab Revenue Market Share by Manufacturer in 2018
Figure Top 3 Atezolizumab Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Atezolizumab Manufacturer (Revenue) Market Share in 2018
Figure Global Atezolizumab Sales and Growth Rate (2014-2019)
Figure Global Atezolizumab Revenue and Growth Rate (2014-2019)
Table Global Atezolizumab Sales by Regions (2014-2019)
Table Global Atezolizumab Sales Market Share by Regions (2014-2019)
Table Global Atezolizumab Revenue by Regions (2014-2019)
Figure Global Atezolizumab Revenue Market Share by Regions (2014-2019)
Figure Global Atezolizumab Revenue Market Share by Regions in 2018
Figure North America Atezolizumab Sales and Growth Rate (2014-2019)
Figure Europe Atezolizumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Atezolizumab Sales and Growth Rate (2014-2019)
Figure South America Atezolizumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Atezolizumab Sales and Growth Rate (2014-2019)
Figure North America Atezolizumab Revenue and Growth Rate (2014-2019)
Table North America Atezolizumab Sales by Countries (2014-2019)
Table North America Atezolizumab Sales Market Share by Countries (2014-2019)
Figure North America Atezolizumab Sales Market Share by Countries (2014-2019)
Figure North America Atezolizumab Sales Market Share by Countries in 2018
Table North America Atezolizumab Revenue by Countries (2014-2019)
Table North America Atezolizumab Revenue Market Share by Countries (2014-2019)
Figure North America Atezolizumab Revenue Market Share by Countries (2014-2019)
Figure North America Atezolizumab Revenue Market Share by Countries in 2018
Figure United States Atezolizumab Sales and Growth Rate (2014-2019)
Figure Canada Atezolizumab Sales and Growth Rate (2014-2019)
Figure Mexico Atezolizumab Sales and Growth Rate (2014-2019)
Figure Europe Atezolizumab Revenue and Growth Rate (2014-2019)
Table Europe Atezolizumab Sales by Countries (2014-2019)
Table Europe Atezolizumab Sales Market Share by Countries (2014-2019)
Table Europe Atezolizumab Revenue by Countries (2014-2019)
Figure Europe Atezolizumab Revenue Market Share by Countries (2014-2019)
Figure Europe Atezolizumab Revenue Market Share by Countries in 2018
Figure Germany Atezolizumab Sales and Growth Rate (2014-2019)
Figure UK Atezolizumab Sales and Growth Rate (2014-2019)
Figure France Atezolizumab Sales and Growth Rate (2014-2019)
Figure Russia Atezolizumab Sales and Growth Rate (2014-2019)
Figure Italy Atezolizumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Atezolizumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Atezolizumab Sales by Countries (2014-2019)
Table Asia-Pacific Atezolizumab Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Atezolizumab Sales Market Share by Countries 2018
Table Asia-Pacific Atezolizumab Revenue by Countries (2014-2019)
Figure Asia-Pacific Atezolizumab Revenue Market Share by Countries 2018
Figure China Atezolizumab Sales and Growth Rate (2014-2019)
Figure Japan Atezolizumab Sales and Growth Rate (2014-2019)
Figure Korea Atezolizumab Sales and Growth Rate (2014-2019)
Figure India Atezolizumab Sales and Growth Rate (2014-2019)
Figure Southeast Asia Atezolizumab Sales and Growth Rate (2014-2019)
Figure South America Atezolizumab Revenue and Growth Rate (2014-2019)
Table South America Atezolizumab Sales by Countries (2014-2019)
Table South America Atezolizumab Sales Market Share by Countries (2014-2019)
Figure South America Atezolizumab Sales Market Share by Countries in 2018
Table South America Atezolizumab Revenue by Countries (2014-2019)
Table South America Atezolizumab Revenue Market Share by Countries (2014-2019)
Figure South America Atezolizumab Revenue Market Share by Countries in 2018
Figure Brazil Atezolizumab Sales and Growth Rate (2014-2019)
Figure Argentina Atezolizumab Sales and Growth Rate (2014-2019)
Figure Colombia Atezolizumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Atezolizumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Atezolizumab Sales by Countries (2014-2019)
Table Middle East and Africa Atezolizumab Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Atezolizumab Sales Market Share by Countries in 2018
Table Middle East and Africa Atezolizumab Revenue by Countries (2014-2019)
Table Middle East and Africa Atezolizumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Atezolizumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Atezolizumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Atezolizumab Sales and Growth Rate (2014-2019)
Figure UAE Atezolizumab Sales and Growth Rate (2014-2019)
Figure Egypt Atezolizumab Sales and Growth Rate (2014-2019)
Figure Nigeria Atezolizumab Sales and Growth Rate (2014-2019)
Figure South Africa Atezolizumab Sales and Growth Rate (2014-2019)
Table Global Atezolizumab Sales by Type (2014-2019)
Table Global Atezolizumab Sales Share by Type (2014-2019)
Table Global Atezolizumab Revenue by Type (2014-2019)
Table Global Atezolizumab Revenue Share by Type (2014-2019)
Figure Global Use: Single Drug Sales Growth (2014-2019)
Figure Global Use: Single Drug Price (2014-2019)
Figure Global Use: Chemotherapy Combination Sales Growth (2014-2019)
Figure Global Use: Chemotherapy Combination Price (2014-2019)
Table Global Atezolizumab Sales by Application (2014-2019)
Table Global Atezolizumab Sales Share by Application (2014-2019)
Figure Global Lung Cancer Sales Growth (2014-2019)
Figure Global Advanced Triple-negative Breast Cancer Sales Growth (2014-2019)
Figure Global Head and Neck Cancer Sales Growth (2014-2019)
Figure Global Urothelial Carcinoma Sales Growth (2014-2019)
Figure Global Renal Cell Carcinoma Sales Growth (2014-2019)
Figure Global Hepatocellular Carcinoma (HCC) Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Atezolizumab Sales, Revenue and Growth Rate (2019-2024)
Table Global Atezolizumab Sales Forecast by Regions (2019-2024)
Table Global Atezolizumab Market Share Forecast by Regions (2019-2024)
Figure North America Sales Atezolizumab Market Forecast (2019-2024)
Figure Europe Sales Atezolizumab Market Forecast (2019-2024)
Figure Asia-Pacific Sales Atezolizumab Market Forecast (2019-2024)
Figure South America Sales Atezolizumab Market Forecast (2019-2024)
Figure Middle East and Africa Sales Atezolizumab Market Forecast (2019-2024)
Table Global Atezolizumab Sales Forecast by Type (2019-2024)
Table Global Atezolizumab Market Share Forecast by Type (2019-2024)
Table Global Atezolizumab Sales Forecast by Application (2019-2024)
Table Global Atezolizumab Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の頭頸部治療の扁平上皮がん市場：市場規模・現状・予測 Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck.In 2018, the global Squamous Cell Carcinoma of the Head and Neck Treatment market size was xx million US$ and it…- 世界の尿路上皮がんの治療市場：市場規模・現状・予測 Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …
- 腎細胞癌治療薬市場：世界及び中国市場分析・予測（～2024年） Renal Cell Carcinoma Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Renal Cell Carcinoma Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Renal Cell Carci…
- 癌免疫療法創薬アウトソーシングの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Cancer Immunotherapy Drug Discovery Outsourcing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years…
- 世界の腎臓がん市場：市場規模・現状・予測 Kidney cancer is a type of cancer that starts in the cells in the kidney.The growth of the market is attributed to increasing incidence of kidney cancers and increasing ill lifestyle changes which gets worsen with addiction of tobacco and alcohol. Furthermore, overexposure to radiation during treatm…